M ultiple recent randomized controlled trials have shown significantly improved clinical outcomes in patients with acute ischemic strokes (AISs) caused by large-vessel occlusion that were treated with mechanical thrombectomy devices within 6-8 hours of stroke onset. 2, 3, 5, 9, 11, 21, 22, 27 Based on these trials, endovascular intervention-as well as intravenous (IV) thrombolysis in eligible cases-has become widely accepted as the treatment of choice in selected patients with early onset moderate to severe AIS caused by large-vessel occlusion in the anterior cerebral circulation.
than currently available, i.e., microcatheter thrombolysis and first-generation thrombectomy devices as opposed to modern stent retrievers and thromboaspiration technologies. 1, 4, 6, 8, 10, 12, 14, 15, [19] [20] [21] 23, 26, [28] [29] [30] Initial selection criteria may also have blunted results from these studies. Nonetheless, subset analysis from IMS-III did show that good clinical outcomes after endovascular intervention strongly depended on the time interval between stroke onset and successful restoration of cerebral perfusion; specifically, longer times to reperfusion resulted in worse clinical outcomes. For example, examination of the IMS-III trial showed that every 30-minute delay in reperfusion reduced the likelihood of a good clinical outcome by 12% (adjusted analysis) to 15% (unadjusted). 15 Therefore, technical factors associated with longer times to reperfusion are of great clinical significance.
Stenosis of the ipsilateral internal carotid artery (ICA) has been described anecdotally to prolong endovascular intervention for AIS by impeding access of the microcatheter to the intracranial arterial occlusive lesion (AOL). However, this delay has not been adequately studied or quantified. Further investigation is warranted to understand the direct impact of ICA stenosis proximal to the occlusive lesion on cerebral collateral blood flow during intervention and the resulting clinical outcomes. To this end, our retrospective review of the IMS-III study data quantifies the effect of ipsilateral ICA stenosis on the technical success of endovascular intervention for large-vessel occlusion of the anterior circulation and defines clinical outcomes in these patients. We hypothesized that severe ipsilateral ICA stenosis would result in prolonged time to reperfusion and worsened clinical outcomes when compared with patients without severe stenosis.
Methods
Detailed descriptions of the IMS-III trial methods and enrollment criteria have been published previously.
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Briefly, the trial was closed short of its planned 900-patient enrollment due to futility: based on the treatment effect observed at 656 patients, there was a less than 20% probability of showing a 10% increase in patients with modified Rankin Scale (mRS) scores of 0-2 at the completion of the planned enrollment. Patients with moderate to severe strokes as determined by a National Institutes of Health Stroke Scale (NIHSS) score ≥ 10 were randomized to either standard IV recombinant tissue plasminogen activator (rTPA) alone or combined intraarterial and IV therapy for AIS within 3 hours of stroke onset; an amendment introduced late in the trial extended this window to 4.5 hours. Further details regarding the IMS-III trial may be obtained with the ClinicalTrials.gov identifier NCT00359424 (https://clinicaltrials.gov/ct2/show/NCT00359424).
The device selected for endovascular intervention was at the discretion of the treating interventionalist. Five methods were approved for revascularization as follows: 1) standard thrombolysis via intraarterial rTPA infusion; 2) ultrasound-enhanced lysis with the EKOS Micro-Sonic SV infusion system (EKOS Corp.); 3) Concentric MERCI System clot retrieval (Concentric Medical, Inc.); 4) Penumbra Aspiration System (Penumbra, Inc.); or 5) the ev3/ Covidien Solitaire FR Revascularization Device (Covidien/ev3).
Patients were then stratified according to the degree of ipsilateral ICA stenosis proximal to the index lesion as determined by immediate pretreatment digital subtraction angiography. "Severe" ICA stenosis in IMS-III was defined as 70% or greater for this analysis. Patients were then compared by age, sex, presenting NIHSS score and Alberta Stroke Program Early CT Score (ASPECTS), site of occlusion, type of aortic arch (if documented), and recanalization status after treatment.
Statistical Analysis
Analyses were performed using 2-sample t-tests for continuous variables and chi-square tests for categorical variables. Subsequently, the mean time to reperfusion, posttreatment modified Thrombolysis in Cerebrovascular Infarction (mTICI) scores, mean infarct volumes at 24 hours, rates of symptomatic intracerebral hemorrhage (sICH), mean mRS score at 90 days, and percentage of mRS scores 0-2 at 90 days were compared between the 2 cohorts. mTICI was represented numerically as mTICI 0 = 1, 1 = 2, 2a = 3, 2b = 4, and 3 = 5, given that alphanumerical values do not lend themselves to statistical analysis. Statistical significance was determined using the Fisher's exact test, with p < 0.05 considered statistically significant. Multiple regression analysis was performed to identify independent predictors of outcome variables.
Results
Of the 369 patients enrolled in the IMS-III trial with a known degree of carotid stenosis determined by angiography, 278 patients underwent endovascular treatment for occlusive lesions of the anterior circulation: 29 (10%) of these patients had severe ICA stenosis/occlusion and 249 patients (90%) had low-grade or no stenosis. At baseline, patients with severe ICA stenosis had significantly lower NIHSS scores than those without severe stenosis. The difference in the proportion of intracranial ICA or M 1 (proximal middle cerebral artery [MCA] ) thrombi in patients with severe ICA stenosis (82.1%) versus those with < 70% stenosis (63.8%) did not reach statistical significance (p = 0.053; Table 1 ). Aortic arch types, determined by CT angiography, were only available for 37% of these patients, but the proportion of difficult (Type III) arches was wellmatched by randomization (data not shown).
A breakdown of devices used in our subset of patients is listed in Table 2 . Patients with severe ICA stenosis had a statistically significant delay in reperfusion that averaged 28 minutes longer than in those with < 70% stenosis (105.7 vs 77.7 minutes, p = 0.004; Table 3 ). Comparison of other variables between those with ≥ 70% versus < 70% ICA stenosis did not reach statistical significance, including distribution of mTICI scores (p = 0.47), percentage of mTICI score 2b-3 (31.0% vs 46.8%, p = 0.11), mean infarct volume at 24 hours (93.8 vs 81.8 ml, p = 0.60), rate of sICH (3.5% vs 8.4%, p = 0.71), mean mRS score (3.4 vs 3.1, p = 0.42), and percentage of mRS scores 0-2 at 90 days (28.6% vs 38.7%, p = 0.30; Table 3 ). Likewise, no sta-tistical disparity was found between patients with ICA occlusion (n = 18) and those with stenosis of 70%-99% (n = 11) in these variables (data not shown). Procedural emboli in the anterior cerebral artery (ACA) territory were noted in 15 patients (6%) with < 70% stenosis and in 5 patients (10%) with severe stenosis. Within our data set, 7 (24.1%) of the 29 patients with severe ICA stenosis required angioplasty or stenting of the extracranial ICA, compared with only 2 (0.8%) of the 249 with < 70% stenosis (p = 0.01).
Variables that were independently associated with worsened outcomes (mean mRS score) at 90 days included older age (p < 0.0001), higher baseline NIHSS score (p < 0.0001), and the absence of reperfusion after intervention (p = 0.001; Table 4 ). Similarly, variables associated with increased time to reperfusion were greater severity of carotid stenosis (p < 0.0001) and higher baseline NIHSS score (p = 0.004; Table 4 ). No variables correlated with either mTICI scores or the rate of sICH to a statistically significant degree (data not shown).
Discussion

Delayed Reperfusion
In quantifying the effect of ICA stenosis on the technical success of endovascular intervention for anterior circulation AIS in IMS-III study patients, we found that mean time to reperfusion was delayed by an average of 28 minutes in patients with ICA stenosis ≥ 70% ipsilateral to the intracranial occlusive lesion. Multiple factors may have contributed to this finding. In comparison with low-grade stenosis, microguidewire navigation across a severely stenotic arterial lumen is more challenging, often involving a lengthy process of trial and error. In some cases, it may be impossible to cross the stenosis, requiring the treating interventionalist to resort to transcirculatory approaches through the anterior or posterior communicating arteries, or to perform angioplasty or stenting of the extracranial ICA for guidewire access. Each of these scenarios is associated with a prolongation of the endovascular intervention and potentially diminished collateral cerebral blood flow to the penumbra during the procedure. The timing of angioplasty/stenting of the cervical ICA during endo- vascular treatment could not be determined from this retrospective review, but these interventions were required in a significantly greater proportion of patients with severe stenosis, as would be expected. The practice of the authors is to initially attempt crossing of the ICA stenosis with the treating microcatheter/revascularization device and/or guide catheter. Balloon angioplasty is performed if lesion traversal is not possible, and stenting is reserved for cases in which the ICA stenosis rebounds and is flow-limiting after completion of the intracranial revascularization.
In the IMS-III trial, a significant proportion of patients were treated by microcatheter thrombolysis, a treatment paradigm that has significant implications regarding our findings. Although thrombolysis is typically performed with low-profile microcatheters that can negotiate very small channels across stenoocclusive carotid lesions, even the smallest commercially available microcatheters can physically occlude the residual lumen of a stenosed carotid, creating a downstream stagnation zone that variably extends to the AOL treatment site. This effect may impede recanalization, as successful enzymatic lysis of the intracranial thrombus partially depends on proximal inflow to drive convective forces and fosters a thrombolytic environment. Theoretically, convective and diffusive forces play an important role in exposing the AOL to lytic drug and plasminogen, preventing local endothelial activation and removing soluble prothrombotic mediators from the treatment site. 24 Furthermore, in patients with acute MCA occlusion and small or absent anterior communicating arteries, placement of a microcatheter across an ipsilateral ICA stenosis may severely diminish collateral flow to MCA territory through leptomeningeal anastomoses. In support of this, our data showed slightly increased infarction volumes in patients with severe ICA stenosis, but this was not statistically significant, perhaps because of patient-to-patient variations in circle of Willis anatomy or poor collateral flow from other vascular distributions.
Modern Implications
In comparison with microcatheter thrombolysis, modern endovascular therapy paradigms that involve stent retrievers and thromboaspiration devices require larger and more complex instrumentation to reach the AOL treatment site. Accordingly, these technologies are more likely to require an initial balloon angioplasty to facilitate navigation through severe ICA stenosis, as well as deployment and recovery of the instrumentation. Therefore, although the actual recanalization of the occluded vessel is demonstrably faster with these modern devices once the treatment site is reached, a delay in accessing the occlusive thrombus is conceivable. The combined treatment of an extracranial ICA obstruction and tandem intracranial occlusion in patients with AIS has been studied retrospectively and reasonable rates of cerebral reperfusion have been demonstrated. 18 If required to gain intracranial access, angioplasty and stenting of the ICA would be expected to increase the overall time required to achieve cerebral reperfusion. Further study regarding the timing and effects of extracranial ICA angioplasty or stenting in stroke intervention with modern technology would be helpful.
Collateral Protection
In our cohort, patients with severe ipsilateral ICA stenosis presented with lower presenting NIHSS and ASPECTS scores. Although this may seem counterintuitive, one could posit that a patient with chronic, severe ICA stenosis likely has well-developed leptomeningeal collaterals that may be protective in the face of AIS. Additionally, neuroprotective mechanisms may be upregulated in this baseline state of relative hypoperfusion. Furthermore, patients with severe stenosis may have chronic ischemic changes that could be erroneously interpreted as contributing to the acute ischemic burden, leading to lower ASPECTS scores. The accuracy of the ASPECTS score for determining regional anterior circulation infarction burden within 3 hours of onset has been found to be up to 96.8% with CT perfusion, whereas accuracy with noncontrast CT imaging is significantly lower at 80%. 17, 31 Of note, CT perfusion was not a requirement of IMS-III and was not routinely performed before intervention.
Clinical Versus Statistical Significance
Although our analysis did not reach statistical significance in all outcome measures, there were slight differences that may be important clinically. Specifically, although a 9% discrepancy in patients achieving an mRS score of 0-2 at 90 days may be clinically meaningful, this subset was not powered to detect any statistically significant difference. Interestingly, stenosis was seemingly protective against symptomatic ICH; however, this finding also was not statistically significant. Multivariate analysis of our data revealed that patients with greater severity of carotid stenosis and higher baseline NIHSS scores had statistically significant delays in reperfusion. Furthermore, 3 variables were associated with significantly worsened outcomes as measured by the mRS at 90 days: older age, higher baseline NIHSS score, and lack of reperfusion during endovascular treatment. These findings give support to our hypothesis that an increased degree of ipsilateral ICA stenosis may worsen clinical outcome in endovascular treatment of stroke. As noted above, variability in cerebrovascular anatomy and collateral reserve may account for the observed lack of statistical significance in unselected patients.
Limitations
Our study has notable limitations. Although the data were prospectively collected, the study is subject to the inherent bias of retrospective review. Furthermore, while the IMS-III trial is the largest to date in the field of stroke intervention, the number of patients with severe ICA stenosis was relatively small (n = 29), which limits the power of our subset analysis. Most importantly, a minority of IMS-III patients underwent treatment with modern endovascular devices, and thus our findings may not translate directly to contemporary therapy. This is a significant limitation, as present-day stent retrievers and thromboaspiration devices have proven to be more expedient and efficacious in stroke intervention than prior technology. A surrogate measure for any treatment delay due to ICA stenosis would potentially be the time from groin puncture to the beginning of intracranial treatment. Unfortunately, the latter time point was not available for analysis given the retrospective nature of our study. Thus, while we posit that the detriment of ICA stenosis would be more severe with larger devices, this remains theoretical.
Additionally, our retrospective review precluded a distinction between atherosclerotic disease and acute thrombus as the culprit for ICA stenosis, as this information was not recorded. Although high-resolution MRI of the ICA wall is capable of making this distinction, this imaging is not practical in a time-sensitive acute setting. Our analysis assumes that most stenoses were due to mural, atherosclerotic disease. Prior studies have shown that up to 8% of AIS may be due to ICA stenosis, 7 whereas acute cardiogenic emboli resulting in extracranial ICA occlusions account for only 0.3% of strokes. 16 Likewise, we were not able to determine the timing of angioplasty or stenting required to traverse the ICA and gain intracranial access given the retrospective nature of the study. Finally, it is difficult to discern any potential effect that ACA infarctions may have had on this small study population. However, given the small number of procedural ACA emboli and similar distribution between our 2 cohorts, it is very unlikely that the presence of ACA infarctions affected our outcome measures.
Clinical Effects
Despite these limitations, our findings have several potential implications for modern endovascular management of stroke patients. Current American Heart Association guidelines support the use of noninvasive vascular imaging studies, such as CT angiography, during the initial evaluation of patients with suspected AIS. 23 This enables pre-interventional identification of severe ipsilateral ICA stenosis in patients who are candidates for embolectomy (approximately 10% of our cohort). In our study, the time required to achieve cerebral reperfusion with interventional therapy was nearly 30 minutes longer in the presence of severe ICA stenosis. In patients with marginal collateral cerebral blood flow who are near the end of their temporal therapeutic window, this may influence a decision not to treat. On the other hand, interventionalists may consider advanced preparation of materials for angioplasty/stenting of the ICA or alternative access strategies (such as transcirculatory catheterization via the anterior or posterior communicating artery).
Overall, our study reveals how extracranial cerebrovascular pathology can alter the transcatheter treatment of intracranial lesions in patients with acute stroke. It is likely that the principles learned from the microcatheter thrombolysis era have implications for modern mechanical embolectomy approaches, albeit the findings may not translate directly. We suspect that the increasing complexity and cross-sectional profile of modern endovascular instruments used for acute stroke therapy may amplify the effects of extracranial stenoocclusive disease if device design and therapeutic strategy do not give consideration to these factors. Technologies that can rapidly accomplish intracranial target revascularization through highly navigable, low-profile delivery systems and enable treatment strategies that postpone angioplasty and stenting of the extracranial obstruction to the end of the procedure should be emphasized. Additionally, while contemporary devices have superior speed and efficacy, some scenarios that encumber the operational efficiency of these technologies may favor some form of intraarterial thrombolytic administration as a preliminary or concurrent maneuver so long as definitive mechanical therapies are not delayed.
Conclusions
In patients who received combined intravenous and intraarterial treatment for AIS within the IMS-III trial, severe ipsilateral ICA stenosis resulted in a statistically significant delay in endovascular reperfusion, averaging 28 minutes. Specifically, patients having a higher baseline NIHSS score and a greater degree of ICA stenosis had a greater delay. Clinical outcomes were significantly worse with older age, higher baseline NIHSS score, and absence of endovascular reperfusion.
